← Back to Search

Behavioural Intervention

Internet-Delivered Psychotherapy for Depression

Q: Are there openings in this research study for new participants?

<p>The clinical trial is presently enrolling patients, as per the information available on clinicaltrials.gov. This study was initially advertised on January 1st of 2023 and its most recent update can be found from February 21st of that year.</p>

Q: How many individuals are presently contributing to this clinical experiment?

<p>Affirmative. As per the clinicaltrials.gov database, this medical trial is actively acquiring participants, with a first post date of January 1st 2023 and an updates on February 21st 2023. There are 13 spots available at one site.</p>

N/A

Recruiting

Led By Julia Kirkham, MD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, mid-point (4-weeks) and after completing the program (8-weeks).

Awards & highlights

Study Summary

This trial will develop, adapt and evaluate a new internet-delivered psychotherapy option (Ger-iPST) to improve access to psychotherapy for older adults with depression.

Who is the study for?

This trial is for people aged 65 or older who feel depressed, have a PHQ-9 score over 5, speak English, and can access the internet. It's not for those with immediate safety concerns like suicidal thoughts, psychotic symptoms, moderate cognitive issues (MoCA < 21), or those already in psychotherapy.Check my eligibility

What is being tested?

The study tests Ger-iPST—an online therapy program designed to help older adults with depression. Participants will do weekly web-based modules and homework through OPTT and get feedback from clinicians plus support calls for technical help.See study design

What are the potential side effects?

Since this is a psychotherapy trial involving counseling rather than medication, typical medical side effects are not expected. However, participants may experience emotional discomfort while discussing personal issues during therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, mid-point (4-weeks) and after completing the program (8-weeks).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, mid-point (4-weeks) and after completing the program (8-weeks).

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, mid-point (4-weeks) and after completing the program (8-weeks). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Measure the effectiveness for symptoms of depression in older adults.

Secondary outcome measures

Examine implementation outcomes - Anxiety symptoms.

Examine implementation outcomes - Disability Assessment.

Examine implementation outcomes - Quality of life.

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Ger-iPSTExperimental Treatment1 Intervention

Prospective participants will be contacted by telephone to confirm eligibility, explain the study protocol, and obtain informed consent. An in-person or videoconference assessment will be used to administer baseline PHQ-9 to confirm enrolment criteria and will be asked questionnaire to gather demographic information. Participants will then be provided with an email link to access the Online Psycho Therapy Tool (OPTT). PHQ-9 will be collected again at the mid-point (4 weeks) and after completing the program through OPTT. Caregivers will be invited to assist the participant if required in completing Ger-iPST modules, and weekly telephone support calls by a research assistant will be provided to assist with any difficulty navigating technical aspects of the Ger-iPST platform.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor

792 Previous Clinical Trials

869,141 Total Patients Enrolled

Hotchkiss Brain Institute, University of CalgaryOTHER

11 Previous Clinical Trials

2,419 Total Patients Enrolled

Julia Kirkham, MDPrincipal InvestigatorUniversity of Calgary

Media Library

Ger-iPST (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05739370 — N/A

Late-Life Depression Research Study Groups: Ger-iPST

Late-Life Depression Clinical Trial 2023: Ger-iPST Highlights & Side Effects. Trial Name: NCT05739370 — N/A

Ger-iPST (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05739370 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there openings in this research study for new participants?

"The clinical trial is presently enrolling patients, as per the information available on clinicaltrials.gov. This study was initially advertised on January 1st of 2023 and its most recent update can be found from February 21st of that year."

Answered by AI

How many individuals are presently contributing to this clinical experiment?

"Affirmative. As per the clinicaltrials.gov database, this medical trial is actively acquiring participants, with a first post date of January 1st 2023 and an updates on February 21st 2023. There are 13 spots available at one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Internet Delivered Psychotherapy for Older Adults

2023. "Internet Delivered Psychotherapy for Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05739370.